Theravance Biopharma, Inc.
TBPHFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Theravance Biopharma, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 1,258,497 | $20.4M | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 10,724 | $174K | SEC filing |
| ASSETMARK, INC | 2026-03-31 | 51 | $828 | SEC filing |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-03-31 | 12,617 | $205K | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 3,874 | $62.9K | SEC filing |
| Caption Management, LLC | 2026-03-31 | 163,704 | $2.66M | SEC filing |
| JANUS HENDERSON GROUP PLC | 2026-03-31 | 378,978 | $6.15M | SEC filing |
| CANADA PENSION PLAN INVESTMENT BOARD | 2026-03-31 | 49,700 | $807K | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 42,666 | $692K | SEC filing |
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 95,115 | $1.54M | SEC filing |
| FIRST TRUST ADVISORS LP | 2026-03-31 | 18,959 | $308K | SEC filing |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2026-03-31 | 208,783 | $3.39M | SEC filing |
| Susquehanna Portfolio Strategies, LLC | 2026-03-31 | 24,032 | $390K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 47,941 | $778K | SEC filing |
| AVIVA PLC | 2026-03-31 | 29,492 | $479K | SEC filing |
| Integrated Quantitative Investments LLC | 2026-03-31 | 49,709 | $807K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 11,009 | $179K | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 2,643 | $42.9K | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 11,772 | $191K | SEC filing |
| EntryPoint Capital, LLC | 2026-03-31 | 49,739 | $807K | SEC filing |
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-15 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −3,329 | 16.39 | SEC filing |
| 2026-06-15 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −6,657 | 16.39 | SEC filing |
| 2026-06-15 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −3,328 | 16.38 | SEC filing |
| 2026-03-16 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −7,767 | 13.92 | SEC filing |
| 2026-03-16 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −15,534 | 14.00 | SEC filing |
| 2026-03-16 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −7,766 | 13.92 | SEC filing |
| 2025-12-03 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −15,534 | 18.75 | SEC filing |
| 2025-12-03 | Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS | Ordinary Shares | S — Open market or private sale | −7,766 | 18.75 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-19 | Miller Aine · SVP, DEV & HEAD OF IRE OFFICE | Ordinary Shares | A — Grant, award, or other acquisition | +18,750 | SEC filing |
| 2026-06-12 | MITCHELL DEAN J · Director | Ordinary Shares | A — Grant, award, or other acquisition | +6,009 | SEC filing |
| 2026-06-12 | PAKIANATHAN DEEPIKA · Director | Ordinary Shares | A — Grant, award, or other acquisition | +6,009 | SEC filing |
| 2026-06-12 | MITCHELL DEAN J · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +13,398 | SEC filing |
| 2026-06-12 | GRAY SUSANNAH · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +13,398 | SEC filing |
| 2026-06-12 | Smaldone Alsup Laurie · Director | Ordinary Shares | A — Grant, award, or other acquisition | +6,009 | SEC filing |
| 2026-06-12 | O'Connor Donal · Director | Ordinary Shares | A — Grant, award, or other acquisition | +6,009 | SEC filing |
| 2026-06-12 | PAKIANATHAN DEEPIKA · Director | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +13,398 | SEC filing |
Showing 8 of 31 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-11-22 | O'Connor Donal · Director | Ordinary Shares | D — Disposition to the issuer | −10,000 | SEC filing |
| 2022-09-16 | GSK PLC · Other | Ordinary Shares | J — Other acquisition or disposition | −9,644,807 | SEC filing |
| 2022-09-16 | GSK PLC · Other | Exchangeable Senior Notes due 2023 | J — Other acquisition or disposition | +unknown | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.